3Indexed trials
drug · Product Intelligence
Atogepant
Pipeline Intelligence
Atogepant: 3 indexed trials, 2 sponsors; 6 linked Orange Book patents and 3 FDA-linked events where matched.
2Sponsors
6Orange Book patent links
3FDA-linked events
Development evidence
NCT03777059Allergan · epilepsyPHASE3
NCT05861427AbbVie · migraine_headachePHASE3
NCT06603558AbbVie · migraine_headacheRECRUITING
FDA / patent evidence
12090148QULIPTA · app 2152062041-07-29
12383545QULIPTA · app 2152062039-06-06
8754096QULIPTA · app 2152062035-09-28
10117836QULIPTA · app 2152062035-01-30
9850246QULIPTA · app 2152062033-03-13
9499545QULIPTA · app 2152062031-11-10
Regulatory context
FDA_EXCLUSIVITYQULIPTA · NCE2026-09-28
FDA_EXCLUSIVITYQULIPTA · I-9092026-04-17
FDA_APPROVALQULIPTA · 2021-09-28
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.